3 Stocks Hitting Low Notes

By Motley Fool Staff | More Articles
November 9, 2009 | Comments (0)

When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.

With that in mind, we'll use the aggregate intelligence of the 140,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.

Here are three such stocks:

Company	Today’s Intraday Price	Industry	Fools Saying Outperform
UltraShort FTSE/Xinhua China 25 ProShares (NYSE: FXP )	$7.54	Dedicated Short Bias Funds	397 of 541
Myriad Genetics, Inc. (Nasdaq: MYGN )	$22.98	Biotechnology	410 of 438
Apollo Group, Inc. (Nasdaq: APOL )	$55.15	Diversified Consumer Services	662 of 788

Source: Motley Fool CAPS, as of November 9, 2009

Top-rated dedicated short bias funds companies:

ProShares UltraShort Lehman 20+Year Treasury (NYSE: TBT ) : Stock price is 23% lower than last year.

Top-rated biotechnology companies:

ImmunoGen, Inc. (Nasdaq: IMGN ) : Stock price is 92% higher than last year.
3SBio, Inc. (ADR) (Nasdaq: SSRX ) : Stock price is 90% higher than last year.

Join us on CAPS to learn more about these and countless other interesting stock ideas.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Disclosure is important to us here at The Motley Fool. The stocks mentioned in this article received their CAPS ratings from participants in The Motley Fool's CAPS service and have hit 52-week lows during today's trading.

No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today’s market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool Pro, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

updated Moments ago Sponsored by:
	DOW	12,874.04	72.81	0.57%
	S&P 500	1,351.77	9.13	0.68%
	NASD	2,931.39	27.51	0.95%

MYGN	$23.47		+0.19	+0.82%
Myriad Genetics		CAPS Rating:

SSRX	$11.80		+0.20	+1.72%
3SBio		CAPS Rating:

IMGN	$13.80		+0.48	+3.56%
ImmunoGen		CAPS Rating:

APOL	$54.03		-0.02	-0.04%
Apollo Group, Inc.		CAPS Rating:

2

3 Stocks Hitting Low Notes

Comments from our Foolish Readers

Be the first one to comment on this article.

Compare Brokers

Report This Comment

Sending report...

Today's Market

Create My Watchlist

You don't seem to be following any stocks yet!

Most Popular Articles

Related Tickers

FXP	$23.18		-0.57	-2.40%
ULTRASHORT FTSE/XI…		CAPS Rating: